Angioedema, Hereditary, Types I and II
1 clinical trials · Condition
◉ Watch Angioedema, Hereditary, Types I and II
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Efficacy and Safety of Different Doses of KVD824 for Prophylactic Treatment of HAE Type I or II (NCT05055258) | KalVista Pharmaceuticals, Ltd. | 2021-11-18 |
Track Angioedema, Hereditary, Types I and II automatically
Every clearance here is in the API, with alerts when new ones post.